Price Chart

Price Chart

Profile

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
URL http://www.ocutx.com
Investor Relations URL https://ocutx.gcs-web.com/
HQ State/Province Massachusetts
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap Core
Next Earnings Release Nov. 04, 2026 (est.)
Last Earnings Release Aug. 03, 2026
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
URL http://www.ocutx.com
Investor Relations URL https://ocutx.gcs-web.com/
HQ State/Province Massachusetts
Sector Health Care
Industry Pharmaceuticals
Equity Style Small Cap Core
Next Earnings Release Nov. 04, 2026 (est.)
Last Earnings Release Aug. 03, 2026
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A